• DOI:10.1111/j.1748-720X.2010.00479.x
• Corpus ID: 38108788

Embryo Stem Cell Research: Ten Years of Controversy

@article{Robertson2010EmbryoSC,
  title={Embryo Stem Cell Research: Ten Years of Controversy},
  author={John A. Robertson},
  journal={The Journal of Law, Medicine \& Ethics},
  year={2010},
  volume={38},
  pages={191 - 203}
}

• J. Robertson
• Published 1 June 2010
• Biology
• The Journal of Law, Medicine & Ethics

Embryonic stem cell (ESC) research has been a source of ethical, legal, and social controversy since the first successful culturing of human ESCs in the laboratory in 1998. The controversy has slowed the pace of stem cell science and shaped many aspects of its subsequent development. This paper assesses the main issues that have bedeviled stem cell progress and identifies the ethical fault lines that are likely to continue. The time is appropriate for such an assessment because the field is poised for a period of rapid development. President Obama has removed the Bush administration’s restrictions on federal funding. A huge influx of federal research funds is in the offing and presumably a more rapid maturing of the science will take place. Stem cell science is also moving into the clinical realm. In March 2009, the Food and Drug Administration (FDA) approved the first clinical trial with an ESC-derived therapy for spinal cord injuries, an important first step — though by no means a final or a sure one — in moving ESC research out of the laboratory into clinical medicine. Finally, recent work with induced pluripotent stem (IPS) cells suggests that non-embryonic sources of pluripotent stem cells may one day be routinely available. Such a development will lessen the temperature of the ethical debate while raising other issues.